跳至主要内容
临床试验/JPRN-UMIN000009209
JPRN-UMIN000009209已完成未知

The study of the effects of oral N/L-type calcium channel blocker cilnidipine on urinary excretions of albumin and podocyte in Japanese hypertensive patients. - The study of the effects of oral N/L-type calcium channel blocker cilnidipine on urinary excretions of albumin and podocyte in Japanese hypertensive patients.

Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine0 个研究点目标入组 50 人开始时间: 2012年10月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • acute illness or malignant tumors drug allergy with pregnant or breast feeding, or candidates with such situations patients who are judged as inappropriate for inclusion by their physicians

研究者

发起方
Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine

相似试验